In brief

The Aesgp (Association of the European Self-Care Industry), Efpia (The European Federation of Pharmaceutical Industries and Associations) and Medicines for Europe (hereafter the “Working Group“) have published a position paper containing a set of recommendations on how to make package leaflets for medicines more comprehensible to patients in order to ensure their appropriate, safe and effective use.

Key takeaways

Among the recommendations made by the Working Group, the following should be highlighted: (i) to create clearer and more easily understandable package leaflets that encourage the correct use of the medicine; (ii) to use simple, easily accessible and concise language, so as to minimize the volume of text and ensure the correct understanding of the relevant information for the patient; (iii) to use a layout and structure that facilitates the reading and understanding; (iv) to introduce a separate section for indications translated into other languages; and (v) to prepare a dedicated text and layout for the electronic package leaflet.